Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Summary

The goal of this clinical research study is learn if taking Femara (letrozole) after a hysterectomy (surgical removal of the uterus) for uterine leiomyosarcoma will delay or prevent the cancer from coming back.

Timeline

Start

2006-12-19

Primary completion

2017-07-13

Completion

2017-07-13

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual”

Drugs

Indications